AtlantiCare, the South Jersey region’s largest healthcare organization and largest non-casino employer in Atlantic City, with more than 6,500 team members and providers, has unveiled its VISION 2030, a six-year initiative that reflects a reimagined approach of AtlantiCare under the leadership of President and CEO Michael J. Charlton, who was appointed to the position last October.
VISION 2030 launches with several new partnerships including: Oracle Health, which represe AtlantiCare’s digital transformation strategy; a clinical training affiliation with Drexel University College of Medicine which will focus on medical education programs that grow and diversify the healthcare talent pipeline; and an affiliation with Cleveland Clinic Cancer Institute and a partnership with Global Neurosciences Institute.
“VISION 2030 puts AtlantiCare in the driver’s seat of a new journey that upends the current paradigms prevalent in healthcare by investing in new technologies, accelerating transformation and ending disparities in care,” said Charlton. “All of this requires AtlantiCare to reimagine our business, make bold decisions and deliver care to our community in a way that is easy, frictionless and, above all else, steeped in humanity. Yes, our goals are ambitious. But they are achievable because our team members are fully invested in the mission and the communities we serve.”
The following goals have been set forth for each of the VISION 2030 pillars:
Serving Community
Workforce Excellence
Accelerating Transformation — AtlantiCare powered by Oracle Health
Growing Market Share — Reinvesting in Programs, Services and People
Cleveland Clinic Cancer Institute – AtlantiCare has entered into an affiliation with Cleveland Clinic Cancer Institute to give patients access to their advanced research, clinical trials, and nationally recognized expertise in cancer treatment and therapies. As one of the top-ranked hospitals in the nation, Cleveland Clinic attracts patients from around the world seeking advanced treatments and expert knowledge. Cleveland Clinic Cancer Institute is collaborating with AtlantiCare to deliver high-quality care to patients through an affiliation designed to enhance and improve clinical quality, service delivery, cost management and patient experience. Through this affiliation, South Jersey residents will have streamlined access to national experts, ensuring them of a care plan that includes the latest advances in cancer treatment.
Oracle Health — “AtlantiCare Powered by Oracle Health” positions AtlantiCare to best serve its communities, patients and workforce, and represents a significant move forward in AtlantiCare’s digital transformation. Through the partnership, Oracle Health is providing the clinical and operational applications and secure, high-performance infrastructure AtlantiCare needs to remain at the forefront of the changing healthcare landscape. AtlantiCare is also one of the first-named Innovation Partners for Oracle’s new generative AI-based Oracle Clinical Digital Assistant (CDA). The technology enables clinicians to use voice commands to reduce time “on the computer” and focus more on patient interactions. AtlantiCare is providing essential feedback to help shape the solution. In addition, AtlantiCare Powered by Oracle Health includes the Comprehensive Command Center, which provides near-real-time enterprise transparency that will help the network perform at peak efficiency, streamline operations and improve care delivery.
Drexel University College of Medicine — AtlantiCare aims to increase the number of graduate medical students it already trains annually as part of the current AtlantiCare medical and residency programs. AtlantiCare has entered a Clinical Training Affiliation with Drexel University College of Medicine to provide clinical training to year 3 and year 4 medical students at its state-of-the-art facilities.
Global Neurosciences Institute — AtlantiCare has entered a clinical partnership with Global Neurosciences Institute (GNI) to take its nationally recognized, comprehensive neurosciences services to the next level of care. GNI brings to the partnership experts who will enhance AtlantiCare’s already robust services. This will include providing a comprehensive array of treatments and therapies, from a complete range of neurosurgical services supporting AtlantiCare’s Joint Commission Comprehensive Stroke Center designation combined with innovative functional neurosurgical procedures to neurology services treating diseases including Alzheimer’s Disease/Cognitive Disorders, Parkinson’s Disease/Movement Disorders, Epilepsy, Multiple Sclerosis and more.
To access more business news, visit NJB News Now.
Related Articles: